InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Longitude Capital Partners III, LLC. Officer active across 3 companies, notably Talaris Therapeutics, Inc.. In total, 5 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €8.8m. History available since 25 January 2022. The latest transaction was filed on 27 April 2022 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Longitude Capital Partners III, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
175,000 shares0Common StockSEC:0000899243-22-016052:0
1,355,000 shares@ US$3.69100.0% of flowCommon StockSEC:0000899243-22-015325:0
Canonical exit: 18 Jul 2022 (T+90)
175,000 shares@ US$27.0021.2% of flowCommon StockSEC:0000899243-22-004271:0
Canonical exit: 3 May 2022 (T+90)
487,451 shares@ US$13.2028.8% of flowCommon StockSEC:0000899243-22-003502:0
2,985,775 sharesCommon StockSEC:0000899243-21-019166:0
5 of 5 declarations
About Longitude Capital Partners III, LLC
Longitude Capital Partners III, LLC is a director and insider, primarily involved with Talaris Therapeutics, Inc.
